021 442 1871 info@capepulmonology.co.za
  • X
  • X
Cape Pulmonology
  • Home
  • About Us
  • Pulmonology
  • General Physician
  • News & Updates
  • Contact Us
    • Contact Dr Symons
    • Contact Ass. Prof. Calligaro
    • Contact Ass. Prof. Peter
    • Contact Prof Dheda
Select Page

New antimycobacterial compound PA 824 show promise in early Phase 2 study in the treatment of tuberculosis

by admin | May 23, 2013 | Uncategorized

Background New drugs, but also shorter, better-tolerated regimens are needed to tackle the high global burden of tuberculosis complicated by drug resistance and retroviral disease. We investigated new multiple-agent combinations over the first 14 days of treatment to...

Recent Posts

  • Pneumonia – prevention and correct treatment made easy
  • Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
  • New antimycobacterial compound PA 824 show promise in early Phase 2 study in the treatment of tuberculosis

Recent Comments

  • Clive Mentoor on New antimycobacterial compound PA 824 show promise in early Phase 2 study in the treatment of tuberculosis
  • Asiphe on Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis

Archives

  • July 2015
  • May 2015
  • May 2013

Categories

  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Contact

Tel: 021 442 1871

Email: info@capepulmonology.co.za

Address

Cape Pulmonology
UCT Private Academic Hospital
Anzio Road
Observatory
Cape Town
7925
021 442 1871

Business Hours

MON. 9:00 a.m. – 5:00 p.m.
TUE. 9:00 a.m. – 5:00 p.m.
WED. 9:00 a.m. – 5:00 p.m.
THU. 9:00 a.m. – 5:00 p.m.
FRI. 9:00 a.m. – 5:00 p.m.
SAT. CLOSED
SUN. CLOSED
  • X
Website designed by Kimberley Kollection